Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Liabilities and Shareholders Equity (2016 - 2025)

InspireMD's Liabilities and Shareholders Equity history spans 16 years, with the latest figure at $69.4 million for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity rose 48.28% year-over-year to $69.4 million; the TTM value through Dec 2025 reached $219.9 million, up 12.78%, while the annual FY2025 figure was $69.4 million, 48.28% up from the prior year.
  • Liabilities and Shareholders Equity reached $69.4 million in Q4 2025 per NSPR's latest filing, down from $78.5 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $78.5 million in Q3 2025 to a low of $19.9 million in Q1 2023.
  • Average Liabilities and Shareholders Equity over 5 years is $44.2 million, with a median of $44.5 million recorded in 2021.
  • Peak YoY movement for Liabilities and Shareholders Equity: surged 558.56% in 2021, then crashed 43.36% in 2023.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $39.7 million in 2021, then plummeted by 37.92% to $24.7 million in 2022, then soared by 93.25% to $47.6 million in 2023, then fell by 1.75% to $46.8 million in 2024, then surged by 48.28% to $69.4 million in 2025.
  • Per Business Quant, the three most recent readings for NSPR's Liabilities and Shareholders Equity are $69.4 million (Q4 2025), $78.5 million (Q3 2025), and $33.3 million (Q2 2025).